Bluejay Diagnostics
BJDX
2 hedge funds and large institutions have $55.7K invested in Bluejay Diagnostics in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 3 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
49% less capital invested
Capital invested by funds: $109K → $55.7K (-$53.3K)
60% less funds holding
Funds holding: 5 → 2 (-3)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$28.5K |
| 2 |
Renaissance Technologies
New York
|
-$17.7K |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
-$9.91K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$6.78K |
| 5 |
SG
StoneX Group
New York
|
-$5.7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $15K | -$17.7K | -1 | -50% |
|
2
Geode Capital Management
Boston,
Massachusetts
| $11.9K | – | – | – |
|
3
Vanguard Group
Malvern,
Pennsylvania
| $6.51K | – | – | – |
|
4
Jane Street
New York
| $5.01K | – | – | – |
|
5
Northern Trust
Chicago,
Illinois
| $4.79K | – | – | – |
|
6
Citadel Advisors
Miami,
Florida
| $4.28K | – | – | – |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $4K | – | – | – |
|
|
VF
8
Virtu Financial
New York
| $4K | – | – | – |
|
9
Osaic Holdings
Scottsdale,
Arizona
| $204 | – | – | – |
|
10
Wells Fargo
San Francisco,
California
| $29 | – | – | – |
|
|
11
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$28.5K | -3 | Closed |
|
|
SM
12
Sabby Management
Miami Beach,
Florida
| – | -$9.91K | -1 | Closed |
|
|
TSS
13
Two Sigma Securities
New York
| – | -$6.78K | -1 | Closed |
|
14
Bank of America
Charlotte,
North Carolina
| – | -$4 | – | – |
|
|
SG
15
StoneX Group
New York
| – | -$5.7K | – | – |
|
16
UBS Group
Zurich,
Switzerland
| – | -$3.82K | – | – |
|
BJDX Hedge Fund Activity: Q1 2023 in Review
2 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Bluejay Diagnostics (BJDX) for Q1 2023, worth a combined $55.7K — down 49% from $109K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of BJDX and 0 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was Susquehanna International Group, exiting entirely with an estimated $28.5K sold.
- 2 institutional investors held Bluejay Diagnostics (BJDX) as of Q1 2023, down from 5 in Q4 2022.
- Funds reported $55.7K of Bluejay Diagnostics stock for Q1 2023, down 49% quarter-over-quarter.
- 0 funds opened new Bluejay Diagnostics positions in Q1 2023 and 3 closed out, a net change of -3 holders.
- The largest Bluejay Diagnostics seller in Q1 2023 was Susquehanna International Group, an estimated $28.5K sold.
Based on aggregated 13F filings for Q1 2023.